Literature summary extracted from
Liu, X.; Cheng, J.C.; Turner, L.S.; Elojeimy, S.; Beckham, T.H.; Bielawska, A.; Keane, T.E.; Hannun, Y.A.; Norris, J.S.
Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy (2009), Expert Opin. Ther. Targets, 13, 1449-1458.
Application
EC Number |
Application |
Comment |
Organism |
---|
3.5.1.23 |
drug development |
development of small molecule drugs, that inhibit AC enzyme activity, is a promising approach for improving standard cancer therapy and patient's clinical outcomes |
Homo sapiens |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
3.5.1.23 |
acid ceramidase maps to 8p22, the region of chromosome 8 most frequently deleted in prostate cancer. Regulation of gene expression by acid ceramidase in prostate cancer cells, overview |
Homo sapiens |
Protein Variants
EC Number |
Protein Variants |
Comment |
Organism |
---|
3.5.1.23 |
additional information |
a germ line single nucleotide polymorphism creates a splice site resulting in alternatively-spliced KLF6 isoforms, termed KLF6 SV1, SV2 and SV3. The splice variants show that SV1 has a counteracting effect on the wild-type KLF6 tumor suppressor activity, thus permitting tumor progression |
Homo sapiens |
Localization
EC Number |
Localization |
Comment |
Organism |
GeneOntology No. |
Textmining |
---|
3.5.1.23 |
lysosome |
predominantly |
Homo sapiens |
5764 |
- |
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
3.5.1.23 |
ceramide + H2O |
Homo sapiens |
- |
sphingosine + fatty acid |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
3.5.1.23 |
Homo sapiens |
- |
- |
- |
Source Tissue
EC Number |
Source Tissue |
Comment |
Organism |
Textmining |
---|
3.5.1.23 |
prostate cancer cell |
acid ceramidase upregulation in prostate cancer |
Homo sapiens |
- |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
3.5.1.23 |
ceramide + H2O |
- |
Homo sapiens |
sphingosine + fatty acid |
- |
? |
|
Subunits
EC Number |
Subunits |
Comment |
Organism |
---|
3.5.1.23 |
dimer |
the 53 kDa acid ceramidase pre-polypeptide undergoes autocatalytic processing into two subunits of 13 and 40 kDa, respectively |
Homo sapiens |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
3.5.1.23 |
acid ceramidase |
- |
Homo sapiens |
Expression
EC Number |
Organism |
Comment |
Expression |
---|
3.5.1.23 |
Homo sapiens |
radiation-induced acid ceramidase upregulation confers resistance to taxane |
up |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
3.5.1.23 |
metabolism |
ceramide metabolism, sphingolipid signaling, and aberrant ceramide signaling and cancer development, overview. Pathways of sphingolipid metabolism, overview |
Homo sapiens |
3.5.1.23 |
additional information |
human acid ceramidase deficiency is associated with Farber disease. It plays a role in androgen depletion therapy and in resistance to chemotherapy and to radiation therapy, overview |
Homo sapiens |
3.5.1.23 |
physiological function |
the enzyme is involved in ceramide metabolism and is a critical regulator of cancer cell growth and/or survival, acid ceramidase upregulation in prostate cancer plays a role in tumor development. A dysfunctional ceramide pathway is responsible for tumor progression and resistance to chemotherapy and radiation |
Homo sapiens |